T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HSKA
2301
DELISTED
Heska Corp
HSKA
| $210K | ﹤0.01% |
3,792
+51
| +1% | +$4.62K |
|
2302
ArcBest
ARCB
$3.14B
| $209K | ﹤0.01% |
11,944
+138
| +1% | +$3.17K |
|
2303
Oxford Industries
OXM
$538M
| $209K | ﹤0.01% |
5,751
+220
| +4% | +$13.5K |
|
|
NVTA
2304
DELISTED
Invitae Corporation
NVTA
| $209K | ﹤0.01% |
+15,284
| New | +$279K |
|
2305
Twist Bioscience
TWST
$7.85B
| $208K | ﹤0.01% |
+6,792
| New | +$183K |
|
|
BFX
2306
DELISTED
BowFlex Inc.
BFX
| $208K | ﹤0.01% |
79,700
+58,700
| +280% | +$160K |
|
|
ZIXI
2307
DELISTED
Zix Corporation
ZIXI
| $208K | ﹤0.01% |
48,358
+293
| +0.6% | +$1.97K |
|
|
USCR
2308
DELISTED
U S Concrete, Inc.
USCR
| $207K | ﹤0.01% |
11,401
+132
| +1% | +$4.06K |
|
2309
Melco Resorts & Entertainment
MLCO
$2.14B
| $205K | ﹤0.01% |
16,524
+4,224
| +34% | +$80.7K |
|
|
UCTT
2310
Ultra Clean Holdings
UCTT
$4.1B
| $205K | ﹤0.01% |
14,841
-10,152
| -41% | -$216K |
|
|
KE
2311
Kimball Electronics
KE
$606M
| $204K | ﹤0.01% |
18,703
+138
| +0.7% | +$2.06K |
|
2312
Tanger
SKT
$4.42B
| $202K | ﹤0.01% |
40,417
+4,540
| +13% | +$55.5K |
|
|
COWN
2313
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $202K | ﹤0.01% |
20,879
+174
| +0.8% | +$2.48K |
|
2314
Asure Software
ASUR
$241M
| $201K | ﹤0.01% |
33,780
| – | – |
|
2315
Akebia Therapeutics
AKBA
$248M
| $200K | ﹤0.01% |
26,392
+740
| +3% | +$5.76K |
|
2316
Precigen
PGEN
$2.45B
| $200K | ﹤0.01% |
58,883
+300
| +0.5% | +$1.29K |
|
|
CONN
2317
DELISTED
Conn's Inc.
CONN
| $198K | ﹤0.01% |
47,343
+27,600
| +140% | +$225K |
|
|
PFBI
2318
DELISTED
Premier Financial Bancorp
PFBI
| $196K | ﹤0.01% |
15,767
+100
| +0.6% | +$1.55K |
|
2319
Seres Therapeutics
MCRB
$47.4M
| $194K | ﹤0.01% |
2,712
+15
| +0.6% | +$1.01K |
|
|
CALY
2320
Callaway Golf Company
CALY
$2.95B
| $194K | ﹤0.01% |
+19,009
| New | +$328K |
|
|
MRC
2321
DELISTED
MRC Global
MRC
| $194K | ﹤0.01% |
45,544
+21,867
| +92% | +$205K |
|
2322
Western New England Bancorp
WNEB
$282M
| $194K | ﹤0.01% |
28,710
+100
| +0.3% | +$850 |
|
2323
Napco Security Technologies
NSSC
$1.39B
| $192K | ﹤0.01% |
25,372
+200
| +0.8% | +$2.35K |
|
|
CHMI
2324
Cherry Hill Mortgage Investment Corp
CHMI
$107M
| $190K | ﹤0.01% |
30,636
-25,800
| -46% | -$338K |
|
|
CIVI
2325
DELISTED
Civitas Resources
CIVI
| $188K | ﹤0.01% |
16,694
+100
| +0.6% | +$1.68K |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.